Run Lu
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 8
- Pharmacology 10
- Inflammatory mediators and NSAID effects 10
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Victor L. Schuster (14 shared papers)Yi Bao (7 shared papers)Naoaki KANAI (6 shared papers)Allan W. Wolkoff (4 shared papers)V. L. Schuster (6 shared papers)Brenda S. Chan (5 shared papers)Joseph A. Satriano (2 shared papers)Michael L. Pucci (5 shared papers)
- Journals
- American Journal of Physiology-Renal Physiology (7 papers)Journal of Clinical Investigation (2 papers)Molecular Pharmacology (2 papers)Transplantation (1 paper)Circulation (1 paper)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Run Lu
21 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 69
- Oncology 726
- Biochemistry 175
- Pharmacology 356
- Rheumatology 78
- Neurology 42
Countries citing papers authored by Run Lu
This map shows the geographic impact of Run Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Lu more than expected).
Fields of papers citing papers by Run Lu
This network shows the impact of papers produced by Run Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Lu. The network helps show where Run Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Run Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 356 | |
| 2 | 1996 | 205 | |
| 3 | 1999 | 144 | |
| 4 | 2004 | 128 | |
| 5 | 2002 | 70 | |
| 6 | 2017 | 70 | |
| 7 | 1996 | 69 | |
| 8 | 1996 | 67 | |
| 9 | 2010 | 65 | |
| 10 | 1996 | 64 | |
| 11 | 1999 | 50 | |
| 12 | 2005 | 50 | |
| 13 | 2002 | 33 | |
| 14 | 1996 | 32 | |
| 15 | 1998 | 29 | |
| 16 | 1996 | 28 | |
| 17 | 1997 | 23 | |
| 18 | 2005 | 19 | |
| 19 | The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates. | 2015 | 15 |
| 20 | OATP-2, a novel prostaglandin transporter Identification of -SH groups near the substrate binding site | 1994 | 1 |
About Run Lu
Run Lu is a scholar working on Biochemistry, Pharmacology, Oncology, Radiology, Nuclear Medicine and Imaging and Transplantation, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Inflammatory mediators and NSAID effects (10 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Cardiovascular Conditions and Treatments (2 papers), Ion Transport and Channel Regulation (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Glaucoma and retinal disorders (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Oncology (726 citations), Biochemistry (175 citations), Pharmacology (356 citations), Rheumatology (78 citations) and Neurology (42 citations). Run Lu has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Victor L. Schuster, Yi Bao, Naoaki KANAI, Allan W. Wolkoff, V. L. Schuster, Brenda S. Chan, Joseph A. Satriano, Michael L. Pucci, Teruhisa Nomura and Yi Bao. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Journal of Clinical Investigation, Molecular Pharmacology, Transplantation and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.